Allergen injection immunotherapy for perennial allergic rhinitis

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2008, Pages

  Calderon, Moises A ^a   Carr, V A ^b   Jacobson, M ^b   Sheikh, A ^b   Durham, S ^b  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOMODULATING AGENT;

ANAPHYLACTIC SHOCK; ANGIONEUROTIC EDEMA; ARTHRALGIA; ASTHMA; BRONCHUS OBSTRUCTION; CLINICAL TRIAL; DERMATOPHAGOIDES; ERYTHEMA; FLUSHING; HEADACHE; HUMAN; IMMUNOTHERAPY; MOULD; PERENNIAL RHINITIS; PET ANIMAL; PRURITUS; QUALITY OF LIFE; RADIOALLERGOSORBENT TEST; REVIEW; RHINITIS; SIDE EFFECT; SKIN TEST; URTICARIA; VISUAL ANALOG SCALE;

EID: 44949134938     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007163     Document Type: Review

References (26)

1. Al-Sayyad 2007 Al Sayyad JJ, Fedorowicz Z, Alhashimi D, Jamal A. Topical nasal steroids for intermittent and persistent allergic rhinitis in children. Cochrane Database of Systematic Reviews 2007, Issue 1.Art. No.: CD003163. DOI:10.1002/14651858.CD003163.pub4.
2. Bauchau 2005 Bauchau V, Durham SR. Epidemiological characterisation of the intermittent and persistent types of allergic rhinitis. Allergy 2005;60(3):350-3.
3. Begg 1994 Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088- 101.
4. Bousquet 1998 Bousquet J, Lockey R, Malling HJ. Allergen immunotherapy: therapeutic vaccines for allergic diseases. WHO position paper. Journal of Allergy and Clinical Immunology 1998;102(4 Pt 1):558-62.
5. Bousquet 2001 Bousquet J, van Cawenberge P, Khaltaev N. Allergic rhinitis and its impact on asthma. ARIA workshop report. Journal of Allergy and Clinical Immunology 2001;108(5):S147-334.
6. Calderon 2007 Calderon MA, Alves B, Jacobson M, Hurwitz B, Sheikh A, Durham SR. Allergen injection immunotherapy for seasonal allergic rhinitis. Cochrane Database of Systematic Reviews 2007, Issue 1.Art. No.: CD001936. DOI:10.1002/14651858.CD001936.pub2.
7. CSM 1986 Committee of the Safety ofMedicines. Desensitising vaccines. British Medical Journal 1986;293:948.
8. Durham 1999 Durham SR, Walker SM, Varga EM, Jacobson MR, O'Brien F, Noble W, et al. Long-term clinical efficacy of grass pollen immunotherapy. New England Journal of Medicine 1999;341(7):468-75.
9. Durham 2006 Durham SR, Church MK. Chapter 1: Principles of allergy diagnosis. Allergy. Philadelphia: Mosby Elsevier, 2006:3-17.
10. Egger 1997 Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. British Medical Journal 1997;315:629-34.
11. Frew 1993 Frew AJ. Injection immunotherapy. British Medical Journal 1993;307:919-23.
12. Gell 1963 Gell PGH, Coombs RRA. Clinical Aspects of Immunology. 1st Edition. Oxford, England: Blackwell, 1963.
13. Gupta 2007 Gupta R, Sheikh A, Strachan DP, Anderson HR. Time trends in allergic disorders in the UK. Thorax 2007;62(1):91-6.
14. Higgins 2006 Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. www.cochrane.org/resources/handbook/hbook.htm (accessed December 2007).
15. Jadad 1996 Jadad AR, Moore A, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomised clinical trials: Is blinding necessary?. Controlled Clinical Trials 1996;17(1):1-12.
16. Juniper 2005 Juniper EF, Stahl E, Doty RL, Simons FER, Allen DB, Howarth PH. Clinical outcomes and adverse effect monitoring in allergic rhinitis. Journal of Allergy and Clinical Immunology 2005;115((3 suppl 1)):S390-413.
17. Lund 1994 Lund VJ, Aaronsen D, Bousquet J, Dahl R, Davies RJ, Durham SR, et al. International consensus report on the diagnosis and management of rhinitis. Allergy 1994;49(Suppl 19):1-34.
18. Malling 1993 Malling HJ, Weeke B. Immunotherapy: Position paper of the European Academy of Allergology and Clinical Immunology. Allergy 1993;48(suppl 14):9-35.
19. RevMan 2003 The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2003.
20. Robinson 2004 Robinson DS, Larche M, Durham SR. Tregs and allergic disease. The Journal of Clinical Investigation 2004;114(10):1389- 97.
21. Ross 2000 Ross RN, Nelson HS, Finegold I. Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: An analysis of randomised, prospective, single or double-blind placebo-controlled studies. Clinical Therapeutics 2000;22(3):342-50.
22. Saleh 2007 Saleh HS, Durham SR. Perennial Rhinitis. British Medical Journal 2007;335(7618):502-7.
23. Sheikh 2007 Sheikh A, Hurwitz B, Shehata Y. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database of Systematic Reviews 2007, Issue 1.Art. No.: CD001563. DOI: 10.1002/14651858.CD001563.pub2.
24. Terreehorst 2003 Terreehorst I, Hak E, Oosting AJ, Tempels-Pavlica Z, de Monchy JGR, Brunijnzeel-Koomen CAFM, et al. Evaluation of Impermeable Covers for Bedding in Patients with Allergic Rhinitis. New England Journal of Medicine 2003;349:237-46.
25. White 1998 White P, Smith H, Baker N, Davis W, Frew A. Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?. Clinical and Experimental Allergy 1998;28:266-70.
26. Wilson 2003 Wilson DR, Torres Lima M, Durham SR. Sublingual immunotherapy for allergic rhinitis. Cochrane Database of Systematic Reviews 2003, Issue 2.Art.No.: CD002893. DOI:10.1002/14651858.CD002893.